AnteoTech Limited (ASX:ADO)
Australia · Delayed Price · Currency is AUD AnteoTech Company Description
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America.
Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation.
The company also offers AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries.
In addition, it provides contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019.
AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
Contact Details
Address: Brisbane Technology Park Eight Mile Plains, 4113 Australia | |
| Phone | 61 7 3219 0085 |
| Website | anteotech.com |
Stock Details
| Ticker Symbol | ADO |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000ADO8 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Merrill Christina Gray AFAIM, B.Min.Tech, B.Sc, M.B.A., MAusIMM | Interim Chief Executive Officer, MD and Director |
| Andrew Cook | Chief Financial Officer and Company Secretary |
| Katrina Byrne | Chief Operating Officer |
| Dr. N. Joe Maeji B.Sc., Ph.D. | Founder and Chief Scientific Officer |
| Manuel Wieser | Chief Technology Officer |
| Tsui Min Lian | Chief Marketing Officer |
| Selahattin Guldu | Executive Vice President of Commercial Banking |
| Ian Steinhardt | Head of Market Operations for Life Sciences |
| Friederike Graser | Director of Strategic Growth Initiatives |